Curcumin and Synthetic Analogs Induce Reactive Oxygen Species and Decreases Specificity Protein (Sp) Transcription Factors by Targeting MicroRNAs

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2012 Dec 1

PMID 23194063

Citations 77

Authors

Shruti U Gandhy

Kyounghyun Kim

Lesley Larsen

Rhonda J Rosengren

Stephen Safe

Affiliations

Soon will be listed here.

Abstract

Background: Curcumin inhibits growth of several cancer cell lines, and studies in this laboratory in bladder and pancreatic cancer cells show that curcumin downregulates specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 and pro-oncogenic Sp-regulated genes. In this study, we investigated the anticancer activity of curcumin and several synthetic cyclohexanone and piperidine analogs in colon cancer cells.

Methods: The effects of curcumin and synthetic analogs on colon cancer cell proliferation and apoptosis were determined using standardized assays. The changes in Sp proteins and Sp-regulated gene products were analysed by western blots, and real time PCR was used to determine microRNA-27a (miR-27a), miR-20a, miR-17-5p and ZBTB10 and ZBTB4 mRNA expression.

Results: The IC50 (half-maximal) values for growth inhibition (24 hr) of colon cancer cells by curcumin and synthetic cyclohexanone and piperidine analogs of curcumin varied from 10 μM for curcumin to 0.7 μM for the most active synthetic piperidine analog RL197, which was used along with curcumin as model agents in this study. Curcumin and RL197 inhibited RKO and SW480 colon cancer cell growth and induced apoptosis, and this was accompanied by downregulation of specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 and Sp-regulated genes including the epidermal growth factor receptor (EGFR), hepatocyte growth factor receptor (c-MET), survivin, bcl-2, cyclin D1 and NFκB (p65 and p50). Curcumin and RL197 also induced reactive oxygen species (ROS), and cotreatment with the antioxidant glutathione significantly attenuated curcumin- and RL197-induced growth inhibition and downregulation of Sp1, Sp3, Sp4 and Sp-regulated genes. The mechanism of curcumin-/RL197-induced repression of Sp transcription factors was ROS-dependent and due to induction of the Sp repressors ZBTB10 and ZBTB4 and downregulation of microRNAs (miR)-27a, miR-20a and miR-17-5p that regulate these repressors.

Conclusions: These results identify a new and highly potent curcumin derivative and demonstrate that in cells where curcumin and RL197 induce ROS, an important underlying mechanism of action involves perturbation of miR-ZBTB10/ZBTB4, resulting in the induction of these repressors which downregulate Sp transcription factors and Sp-regulated genes.

Citing Articles

The crosstalk between non-coding RNAs and oxidative stress in cancer progression.

Sun Q, Lei X, Yang X Genes Dis. 2025; 12(3):101286.

PMID: 40028033 PMC: 11870203. DOI: 10.1016/j.gendis.2024.101286.

Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer.

Hon K, Naidu R Antioxidants (Basel). 2024; 13(7).

PMID: 39061884 PMC: 11273411. DOI: 10.3390/antiox13070815.

Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics.

Sumaira S, Vijayarathna S, Hemagirri M, Adnan M, Hassan M, Patel M Noncoding RNA Res. 2024; 9(4):1140-1158.

PMID: 39022680 PMC: 11250886. DOI: 10.1016/j.ncrna.2024.06.003.

Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach.

Hon K, Zainal Abidin S, Abas F, Othman I, Naidu R Int J Mol Sci. 2024; 25(6).

PMID: 38542474 PMC: 10970808. DOI: 10.3390/ijms25063503.

Interaction of Thiol Antioxidants with α,β-Unsaturated Ketone Moiety: Its Implication for Stability and Bioactivity of Curcuminoids.

Lee B, Song E, Hong J Molecules. 2023; 28(23).

PMID: 38067442 PMC: 10707499. DOI: 10.3390/molecules28237711.

References

Kim K, Chadalapaka G, Lee S, Yamada D, Sastre-Garau X, Defossez P . Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene. 2011; 31(8):1034-44. PMC: 3288192. DOI: 10.1038/onc.2011.296. View

Ohori H, Yamakoshi H, Tomizawa M, Shibuya M, Kakudo Y, Takahashi A . Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther. 2006; 5(10):2563-71. DOI: 10.1158/1535-7163.MCT-06-0174. View

Torti D, Trusolino L . Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils. EMBO Mol Med. 2011; 3(11):623-36. PMC: 3377106. DOI: 10.1002/emmm.201100176. View

Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi B, Khar A . Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett. 1999; 456(2):311-4. DOI: 10.1016/s0014-5793(99)00969-2. View

Milacic V, Banerjee S, Landis-Piwowar K, Sarkar F, Majumdar A, Dou Q . Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res. 2008; 68(18):7283-92. PMC: 2556983. DOI: 10.1158/0008-5472.CAN-07-6246. View

Yadav B, Taurin S, Rosengren R, Schumacher M, Diederich M, Somers-Edgar T . Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorg Med Chem. 2010; 18(18):6701-7. DOI: 10.1016/j.bmc.2010.07.063. View

Higgins K, Abdelrahim M, Liu S, Yoon K, Safe S . Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins. Biochem Biophys Res Commun. 2006; 345(1):292-301. DOI: 10.1016/j.bbrc.2006.04.111. View

Chintharlapalli S, Papineni S, Lee S, Lei P, Jin U, Sherman S . Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins. Mol Carcinog. 2011; 50(9):655-67. PMC: 3128656. DOI: 10.1002/mc.20738. View

Somers-Edgar T, Taurin S, Larsen L, Chandramouli A, Nelson M, Rosengren R . Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines. Invest New Drugs. 2009; 29(1):87-97. DOI: 10.1007/s10637-009-9339-0. View

10.

Chadalapaka G, Jutooru I, Burghardt R, Safe S . Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. Mol Cancer Res. 2010; 8(5):739-50. PMC: 2872686. DOI: 10.1158/1541-7786.MCR-09-0493. View

11.

Adrian G, Seto E, Fischbach K, Rivera E, Adrian E, Herbert D . YY1 and Sp1 transcription factors bind the human transferrin gene in an age-related manner. J Gerontol A Biol Sci Med Sci. 1996; 51(1):B66-75. DOI: 10.1093/gerona/51a.1.b66. View

12.

Papineni S, Chintharlapalli S, Abdelrahim M, Lee S, Burghardt R, Abudayyeh A . Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. Carcinogenesis. 2009; 30(7):1193-201. PMC: 2704282. DOI: 10.1093/carcin/bgp092. View

13.

Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S . Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. Free Radic Biol Med. 2008; 45(10):1403-12. DOI: 10.1016/j.freeradbiomed.2008.08.014. View

14.

Pathi S, Jutooru I, Chadalapaka G, Sreevalsan S, Anand S, Thatcher G . GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Mol Cancer Res. 2010; 9(2):195-202. PMC: 3069691. DOI: 10.1158/1541-7786.MCR-10-0363. View

15.

Kunnumakkara A, Diagaradjane P, Anand P, Harikumar K, Kuzhuvelil H, Deorukhkar A . Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer. 2009; 125(9):2187-97. DOI: 10.1002/ijc.24593. View

16.

Abdelrahim M, Baker C, Abbruzzese J, Safe S . Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. J Natl Cancer Inst. 2006; 98(12):855-68. DOI: 10.1093/jnci/djj232. View

17.

Ammendola R, Mesuraca M, Russo T, Cimino F . Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues. J Biol Chem. 1992; 267(25):17944-8. View

18.

Chadalapaka G, Jutooru I, Safe S . Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells. Carcinogenesis. 2012; 33(4):886-94. PMC: 3324448. DOI: 10.1093/carcin/bgs102. View

19.

Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S . Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer. 2011; 11:371. PMC: 3170653. DOI: 10.1186/1471-2407-11-371. View

20.

Jutooru I, Chadalapaka G, Abdelrahim M, Basha M, Samudio I, Konopleva M . Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Mol Pharmacol. 2010; 78(2):226-36. PMC: 2917860. DOI: 10.1124/mol.110.064451. View